Stockreport

Alumis to Participate in Upcoming February Investor Conferences

Alumis Inc.  (ALMS) 
PDF SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies [Read more]